Protection against endotoxic shock by bactericidal/permeability-increasing protein in rats.

Abstract	Bactericidal/permeability-increasing protein (BPI) is a neutrophil primary granule protein that inhibits effects of LPS in vitro. The current study examined the effects of BPI on hemodynamics, mortality, and circulating endotoxin and cytokines in conscious rats with endotoxic shock. Catheters were implanted into the right femoral artery and vein. 1 d later, human recombinant BPI (10 mg/kg) or vehicle was intravenously injected immediately, 30 min, or 2 h after intravenous injection of LPS (7.5 mg/kg). Mean arterial pressure (MAP) and heart rate were monitored and blood was collected before and after injection. BPI given immediately or 30 min after LPS prevented the LPS-induced reduction in MAP at 4-8 h and markedly reduced mortality. BPI given 2 h after LPS injection had no protective effect. BPI treated immediately after LPS reduced the circulating levels of endotoxin and IL-6 but increased the circulating levels of TNF. We propose that BPI exerts its protective effect through a TNF-independent mechanism, by inhibiting endotoxin-stimulated production of IL-6.
Authors	H Jin, R Yang, S Marsters, A Ashkenazi, S Bunting, M N Marra, R W Scott, J B Baker
Journal	The Journal of clinical investigation (J Clin Invest) Vol. 95 Issue 4 Pg. 1947-52 (Apr 1995) ISSN: 0021-9738 [Print] United States
PMID	7706502 (Publication Type: Journal Article)
Chemical References	Anti-Infective Agents Antimicrobial Cationic Peptides Blood Proteins Endotoxins Interleukin-6 Lipopolysaccharides Membrane Proteins Recombinant Proteins Tumor Necrosis Factor-alpha bactericidal permeability increasing protein
Topics	Animals Anti-Infective Agents (therapeutic use) Antimicrobial Cationic Peptides Blood Pressure (drug effects) Blood Proteins (therapeutic use) Endotoxins (blood, pharmacology) Heart Rate (drug effects) Hemodynamics (drug effects) Hypotension (drug therapy) Interleukin-6 (blood) Lipopolysaccharides (pharmacology) Male Membrane Proteins Rats Rats, Sprague-Dawley Recombinant Proteins (therapeutic use) Shock, Septic (mortality, therapy) Time Factors Tumor Necrosis Factor-alpha (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!